At a Glance
Northpond Ventures was founded in 2007 by David Fargo and has established itself as a leading life sciences venture capital firm focused on transforming breakthrough scientific discoveries into life-changing medicines and healthcare solutions. Based in Bethesda, Maryland, near the National Institutes of Health, Northpond leverages its proximity to world-class research institutions and regulatory agencies to identify and support the most promising scientific innovations. The firm invests across the life sciences spectrum, from biotechnology and pharmaceuticals to medical devices and agricultural technology, typically participating in seed through growth-stage rounds. Northpond gained significant recognition as an early investor in Moderna, supporting the company from its Series A through its groundbreaking mRNA COVID-19 vaccine development and public offering. The firm's investment approach combines deep scientific expertise with extensive industry networks, providing portfolio companies with strategic guidance on drug development, regulatory pathways, and partnership opportunities with large pharmaceutical companies. Northpond's team includes experienced life sciences investors, former biotech executives, and scientific advisors who work closely with portfolio companies to navigate the complex path from laboratory to market.
“Investing in life sciences companies that harness breakthrough scientific discoveries to develop transformational medicines and medical technologies.”
Northpond Ventures primarily invests at the Seed, Series A, Series B+ stages. This means they focus on companies that are building their initial product and finding product-market fit.
Northpond Ventures is headquartered in Bethesda, MD. Many of their portfolio companies are also based in this region, though they invest across geographies.
Northpond Ventures focuses on investments in Biotech, Digital Health. Their portfolio reflects deep expertise and networks within these sectors.
Northpond Ventures's typical investment check size ranges from $2M to $25M. Actual amounts may vary based on the stage, sector, and specific opportunity.
Northpond Ventures manages approximately $1.5B in assets under management (AUM) across their funds.
